1 |
0,5 mg prevenar i.m. |
- |
- |
- |
- |
051 1件: 51 💬 |
2 |
0,5 mg seasonal influenza vaccine i.m. |
- |
- |
- |
- |
051 1件: 51 💬 |
3 |
0.9% sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 4件: 6 , 14, 51, 53 💬 |
4 |
1-(6-benzothiazolylsulfonyl)-5-chloro-1h-indole-2-butanoic acid |
Butyric Acid |
1件: D05866 D05866 💬 |
- |
- |
051 1件: 51 💬 |
5 |
1-22460 |
- |
- |
- |
- |
051 1件: 51 💬 |
6 |
10% nitroglycerine in propylene glycol, usp |
Nitroglycerin |
2件: D00078 D00078, D00515 D00515 💬 |
- |
- |
051 1件: 51 💬 |
7 |
3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(n-butyloxylcarbamate)-sulphonamide] sodium salt |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
8 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
9 |
Abituzumab |
Abituzumab |
- |
- |
- |
051 1件: 51 💬 |
10 |
Abituzumab 1500 mg |
Abituzumab |
- |
- |
- |
051 1件: 51 💬 |
11 |
Abituzumab 500 mg |
Abituzumab |
- |
- |
- |
051 1件: 51 💬 |
12 |
Abr-215757 |
- |
- |
- |
- |
049 2件: 49, 51 💬 |
13 |
Acetaminophen |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
14 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
15 |
Acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 16件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
16 |
Acetylsalicylic acid |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 4件: 13, 46, 51, 210 💬 |
17 |
Achim as solute (10^9 intestinal microbes/ml) |
- |
- |
- |
- |
051 1件: 51 💬 |
18 |
Acotiamide |
Acotiamide |
- |
- |
- |
051 1件: 51 💬 |
19 |
Act-064992 |
- |
- |
- |
- |
051 5件: 51, 85, 86, 88, 210 💬 |
20 |
Act-293987 |
- |
- |
- |
- |
051 3件: 51, 86, 88 💬 |
21 |
Adempas |
- |
- |
- |
- |
051 5件: 51, 86, 88, 225, 299 💬 |
22 |
Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
23 |
Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
24 |
Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
25 |
Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
26 |
Administration of rituximab and methylprednisolone |
Methylprednisolone |
7件: D00407 D00407, D00751 D00751, D00979 D00979, D02994 D02994, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
MS4A1 2件: MS4A1, NR3C1 💬 |
Hematopoietic cell lineage 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
051 1件: 51 💬 |
27 |
Adsvf application in the right hand |
- |
- |
- |
- |
051 1件: 51 💬 |
28 |
Aimspro |
- |
- |
- |
- |
013 2件: 13, 51 💬 |
29 |
Air |
- |
- |
- |
- |
003 7件: 3 , 51, 58, 85, 97, 193, 299 💬 |
30 |
Ajulemic acid |
Ajulemic acid |
1件: D11312 D11312 💬 |
CNR2 1件: CNR2 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
050 3件: 50, 51, 299 💬 |
31 |
Al |
- |
- |
- |
- |
005 9件: 5 , 6 , 7 , 28, 51, 67, 86, 114, 127 💬 |
32 |
Albumin |
- |
- |
- |
- |
002 3件: 2 , 20, 51 💬 |
33 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
34 |
Alginic acid |
Alginic acid |
1件: D02324 D02324 💬 |
- |
- |
051 1件: 51 💬 |
35 |
Allogeneic mesenchymal stem cells (allomsc) |
- |
- |
- |
- |
051 2件: 51, 53 💬 |
36 |
Alpha-2c ar antagonist |
- |
- |
- |
- |
051 1件: 51 💬 |
37 |
Alprostadil |
Alprostadil |
2件: D00180 D00180, D02705 D02705 💬 |
PTGER1 1件: PTGER1 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
051 2件: 51, 70 💬 |
38 |
Am-01 |
- |
- |
- |
- |
051 1件: 51 💬 |
39 |
Ambrisentan |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 7件: 51, 84, 85, 86, 88, 210, 211 💬 |
40 |
Amlodipine |
Amlodipine |
3件: D00615 D00615, D02914 D02914, D07450 D07450 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 3件: 51, 67, 298 💬 |
41 |
Amlodipine gel |
Amlodipine |
3件: D00615 D00615, D02914 D02914, D07450 D07450 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
42 |
Anaerobically cultivated human intestinal microbiota |
- |
- |
- |
- |
051 1件: 51 💬 |
43 |
Anaerobically cultivated medium |
- |
- |
- |
- |
051 1件: 51 💬 |
44 |
Anti-ct51 antigen mab |
- |
- |
- |
- |
051 1件: 51 💬 |
45 |
Anti-human t-lymphocyte immunoglobulin from rabbits |
- |
- |
- |
- |
051 1件: 51 💬 |
46 |
Anti-integrin alphav mab |
- |
- |
- |
- |
051 1件: 51 💬 |
47 |
Anti-pandemic h1n1 influenza vaccine |
- |
- |
- |
- |
046 5件: 46, 49, 50, 51, 53 💬 |
48 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
49 |
Anti-thymocyte globulin, rabbit |
Rabbit |
- |
- |
- |
051 1件: 51 💬 |
50 |
Asasantin retard |
- |
- |
- |
- |
051 1件: 51 💬 |
51 |
Asasantin retard ® |
- |
- |
- |
- |
051 1件: 51 💬 |
52 |
Asc |
- |
- |
- |
- |
036 4件: 36, 51, 96, 97 💬 |
53 |
Aspirin |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 11件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
54 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
55 |
Auc of mpa measure |
- |
- |
- |
- |
051 1件: 51 💬 |
56 |
Autologous asc |
- |
- |
- |
- |
051 1件: 51 💬 |
57 |
Autologous stem cells |
- |
- |
- |
- |
013 2件: 13, 51 💬 |
58 |
Autologous stemcell transplantation with cd (cluster of differentiation) 34 selected stem cells |
- |
- |
- |
- |
051 1件: 51 💬 |
59 |
Avid200 |
- |
- |
- |
- |
051 1件: 51 💬 |
60 |
Aviptadil |
Aviptadil |
- |
- |
- |
049 4件: 49, 51, 85, 86 💬 |
61 |
Bay63-2521 |
- |
- |
- |
- |
051 3件: 51, 86, 299 💬 |
62 |
Beam |
Tricyclazole |
- |
- |
- |
006 2件: 6 , 51 💬 |
63 |
Belimumab |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 10件: 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬 |
64 |
Belumosudil (kd025) |
- |
- |
- |
- |
051 1件: 51 💬 |
65 |
Bermekimab |
Bermekimab |
1件: D11253 D11253 💬 |
IL1A 1件: IL1A 💬 |
AGE-RAGE signaling pathway in diabetic complications 21件: AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus |
051 1件: 51 💬 |
66 |
Bh4 |
- |
- |
- |
- |
051 5件: 51, 86, 124, 240, 299 💬 |
67 |
Bibf 1120 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
68 |
Biopsy |
- |
- |
- |
- |
019 2件: 19, 51 💬 |
69 |
Blood coagulation factor xiii |
Factor XIII (human) |
- |
- |
- |
051 1件: 51 💬 |
70 |
Blood sample |
- |
- |
- |
- |
008 13件: 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
71 |
Blood samples |
- |
- |
- |
- |
013 8件: 13, 41, 46, 51, 61, 97, 227, 271 💬 |
72 |
Blood sampling |
- |
- |
- |
- |
013 5件: 13, 17, 19, 51, 96 💬 |
73 |
Bms-986020 |
BMS-986020 |
- |
- |
- |
051 2件: 51, 85 💬 |
74 |
Bortezomib |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
75 |
Bosentan |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
76 |
Bosentan (tracleer) |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
77 |
Bosentan 125 mg |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
78 |
Bosentan 62.5 mg |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
79 |
Bosentan group |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
80 |
Bosentan monohydrate |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 4件: 51, 84, 86, 88 💬 |
81 |
Botox |
- |
- |
- |
- |
002 6件: 2 , 6 , 13, 51, 149, 226 💬 |
82 |
Botox® solution |
- |
- |
- |
- |
051 1件: 51 💬 |
83 |
Botulinum toxin a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 4件: 13, 51, 149, 226 💬 |
84 |
Botulinum toxin type b |
Botulinum Toxin Type B |
1件: D02735 D02735 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 3件: 2 , 6 , 51 💬 |
85 |
Botulinum toxin type b (2500 units / vial) |
Botulinum Toxin Type B |
1件: D02735 D02735 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
051 1件: 51 💬 |
86 |
Botulinum toxin(botox) |
- |
- |
- |
- |
051 1件: 51 💬 |
87 |
Bovine type i collagen |
Bovine type I collagen |
- |
- |
- |
051 1件: 51 💬 |
88 |
Brentuximab |
Brentuximab vedotin |
1件: D09587 D09587 💬 |
TNFRSF8 10件: TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 11件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
049 2件: 49, 51 💬 |
89 |
Brentuximab vedotin |
Brentuximab vedotin |
1件: D09587 D09587 💬 |
TNFRSF8 10件: TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 11件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
049 2件: 49, 51 💬 |
90 |
Brodalumab |
Brodalumab |
1件: D10061 D10061 💬 |
IL17RA 1件: IL17RA 💬 |
Cytokine-cytokine receptor interaction 2件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway |
037 2件: 37, 51 💬 |
91 |
Bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 8件: 46, 51, 53, 70, 96, 168, 226, 298 💬 |
92 |
Buspirone |
Buspirone |
2件: D00702 D00702, D07593 D07593 💬 |
DRD2 2件: DRD2, HTR1A 💬 |
Alcoholism 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 2件: 6 , 51 💬 |
93 |
Busulfan |
Busulfan |
1件: D00248 D00248 💬 |
- |
- |
019 13件: 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬 |
94 |
Butanoic acid |
Butyric Acid |
1件: D05866 D05866 💬 |
- |
- |
034 3件: 34, 51, 97 💬 |
95 |
C-82 topical gel, 1% |
- |
- |
- |
- |
051 1件: 51 💬 |
96 |
C21 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
97 |
C225 |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
98 |
Calcipotriene |
Calcipotriol |
1件: D01125 D01125 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
051 1件: 51 💬 |
99 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
100 |
Calcium channel blockers |
Calcium |
- |
- |
- |
051 1件: 51 💬 |
101 |
Cam2043 |
- |
- |
- |
- |
051 1件: 51 💬 |
102 |
Campath |
- |
- |
- |
- |
019 12件: 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
103 |
Capillarema |
- |
- |
- |
- |
051 1件: 51 💬 |
104 |
Carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
105 |
Carbon dioxide |
Activated charcoal |
2件: D00004 D00004, D03251 D03251 💬 |
- |
- |
050 3件: 50, 51, 97 💬 |
106 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
107 |
Cc-4047 |
- |
- |
- |
- |
028 2件: 28, 51 💬 |
108 |
Cd |
- |
- |
- |
- |
006 6件: 6 , 46, 51, 96, 97, 265 💬 |
109 |
Cd34 selected autologous hematopoietic cells |
- |
- |
- |
- |
051 1件: 51 💬 |
110 |
Cd34+sc |
- |
- |
- |
- |
051 1件: 51 💬 |
111 |
Cetuximab |
Cetuximab |
1件: D03455 D03455 💬 |
EGFR 1件: EGFR 💬 |
Adherens junction 46件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis |
034 5件: 34, 51, 86, 89, 331 💬 |
112 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
113 |
Cialis |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
114 |
Cilostazol |
Cilostazol |
1件: D01896 D01896 💬 |
PDE3A 3件: PDE3A, PDE3B, TBXA2R 💬 |
Apelin signaling pathway 14件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 2件: 51, 70 💬 |
115 |
Clobetasol |
Clobetasol |
1件: D07715 D07715 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
039 4件: 39, 46, 51, 162 💬 |
116 |
Cuprimine (penicillamine) |
Penicillamine |
1件: D00496 D00496 💬 |
- |
- |
051 1件: 51 💬 |
117 |
Currently available therapy in the community |
- |
- |
- |
- |
051 1件: 51 💬 |
118 |
Cutaneous iontophoresis of treprostinil |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 1件: 51 💬 |
119 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
120 |
Cyclophosphamide injection 1g |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
050 3件: 50, 51, 52 💬 |
121 |
Dabigatran |
Dabigatran |
1件: D09707 D09707 💬 |
F2 1件: F2 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
051 4件: 51, 85, 91, 124 💬 |
122 |
Dabigatran etexilate |
Dabigatran |
2件: D07144 D07144, D09707 D09707 💬 |
F2 1件: F2 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
051 1件: 51 💬 |
123 |
Dasatinib |
Dasatinib |
2件: D03658 D03658, D06414 D06414 💬 |
ABL1 8件: ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 |
Acute myeloid leukemia 74件: Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
051 2件: 51, 85 💬 |
124 |
Depot leuprolide acetate 3.75 mg |
Acetate |
2件: D00989 D00989, D08113 D08113 💬 |
GNRHR 1件: GNRHR 💬 |
GnRH signaling pathway 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction |
051 1件: 51 💬 |
125 |
Dersimelagon |
- |
- |
- |
- |
051 2件: 51, 254 💬 |
126 |
Device: air filled balloon catheter |
- |
- |
- |
- |
051 1件: 51 💬 |
127 |
Device: fractional carbon dioxide laser |
Activated charcoal |
2件: D00004 D00004, D03251 D03251 💬 |
- |
- |
051 1件: 51 💬 |
128 |
Device: manual toothbrush |
- |
- |
- |
- |
051 1件: 51 💬 |
129 |
Device: manual toothbrush and water flosser (philips sonicare airfloss) |
Water |
1件: D00001 D00001 💬 |
- |
- |
051 1件: 51 💬 |
130 |
Device: measurment with aspirational medical device |
- |
- |
- |
- |
051 1件: 51 💬 |
131 |
Device: measurment with cutometer mpa 580 |
- |
- |
- |
- |
051 1件: 51 💬 |
132 |
Device: serial night time position splint |
- |
- |
- |
- |
051 1件: 51 💬 |
133 |
Device: solid state catheter |
- |
- |
- |
- |
051 1件: 51 💬 |
134 |
Device: sonic toothbrush |
- |
- |
- |
- |
051 1件: 51 💬 |
135 |
Device: sonic toothbrush (philips sonicare) and water flosser (philips sonicare airfloss) |
Water |
1件: D00001 D00001 💬 |
- |
- |
051 1件: 51 💬 |
136 |
Device: the ozone generator device (human pro medic, german) |
Ozone |
- |
- |
- |
051 1件: 51 💬 |
137 |
Device: ultraviolet a1 phototherapy (uva1) |
- |
- |
- |
- |
051 1件: 51 💬 |
138 |
Di-17e6 |
- |
- |
- |
- |
051 1件: 51 💬 |
139 |
Diagnostic test: cmri |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
140 |
Diagnostic test: imaging |
- |
- |
- |
- |
051 1件: 51 💬 |
141 |
Diagnostic test: p-mpa concentration |
- |
- |
- |
- |
051 1件: 51 💬 |
142 |
Diagnostic test: pulmonary function test |
- |
- |
- |
- |
051 1件: 51 💬 |
143 |
Digna p144 cream |
- |
- |
- |
- |
051 1件: 51 💬 |
144 |
Diltiazem |
Diltiazem |
3件: D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 3件: 51, 58, 86 💬 |
145 |
Diltiazem gel 2% |
Diltiazem |
3件: D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
146 |
Dimethyl fumarate |
Dimethyl fumarate |
1件: D03846 D03846 💬 |
KEAP1 1件: KEAP1 💬 |
Fluid shear stress and atherosclerosis 4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 4件: 13, 51, 86, 296 💬 |
147 |
Dimethyl fumarate (dmf) |
Dimethyl fumarate |
1件: D03846 D03846 💬 |
KEAP1 1件: KEAP1 💬 |
Fluid shear stress and atherosclerosis 4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 3件: 13, 51, 86 💬 |
148 |
Diphenhydramine |
Diphenhydramine |
6件: D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 8件: 11, 49, 51, 70, 86, 96, 222, 256 💬 |
149 |
Dipyridamole |
Dipyridamole |
1件: D00302 D00302 💬 |
PDE4A 2件: PDE4A, PDE5A 💬 |
Metabolic pathways 6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 5件: 46, 49, 51, 66, 224 💬 |
150 |
Divalproex sodium |
- |
- |
- |
- |
051 1件: 51 💬 |
151 |
Domperidone |
Domperidone |
2件: D01745 D01745, D07868 D07868 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 5件: 6 , 13, 17, 51, 230 💬 |
152 |
Double-blind rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
051 1件: 51 💬 |
153 |
Drug treatment |
- |
- |
- |
- |
046 4件: 46, 51, 74, 271 💬 |
154 |
Dupilumab |
Dupilumab |
1件: D10354 D10354 💬 |
IL4R 1件: IL4R 💬 |
Cytokine-cytokine receptor interaction 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
051 4件: 51, 98, 160, 162 💬 |
155 |
Dupilumab 300mg solution for injection |
Dupilumab |
1件: D10354 D10354 💬 |
IL4R 1件: IL4R 💬 |
Cytokine-cytokine receptor interaction 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
051 1件: 51 💬 |
156 |
Edta |
Edetic acid |
8件: D00052 D00052, D00571 D00571, D01802 D01802, D03943 D03943, D03944 D03944, D03945 D03945, D03946 D03946, D03947 D03947 💬 |
- |
- |
051 2件: 51, 60 💬 |
157 |
Ema/chmp/212874/2015 |
- |
- |
- |
- |
051 1件: 51 💬 |
158 |
Emd 525797 |
- |
- |
- |
- |
051 1件: 51 💬 |
159 |
Endoprost |
- |
- |
- |
- |
051 1件: 51 💬 |
160 |
Endoprost - 0.05 mg/0.5 ml concentrato per soluzione per infusione 1 fiala |
- |
- |
- |
- |
051 1件: 51 💬 |
161 |
Endoprost 0,05mg/0,5ml 1f |
- |
- |
- |
- |
051 1件: 51 💬 |
162 |
Endoprost 50*infus 1f 0,050mg/ |
- |
- |
- |
- |
051 1件: 51 💬 |
163 |
Endothelin receptor blocker |
- |
- |
- |
- |
051 1件: 51 💬 |
164 |
Erbitux |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
165 |
Esbriet |
- |
- |
- |
- |
046 4件: 46, 51, 85, 228 💬 |
166 |
Ethanol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 4件: 51, 97, 279, 280 💬 |
167 |
Ex vivo cultured human mesenchymal stem cells |
- |
- |
- |
- |
051 1件: 51 💬 |
168 |
Factor xiii |
Factor XIII (human) |
- |
- |
- |
051 3件: 51, 97, 288 💬 |
169 |
Fasudil |
Fasudil |
1件: D07941 D07941 💬 |
ROCK1 2件: ROCK1, ROCK2 💬 |
Axon guidance 22件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 2件: 2 , 51 💬 |
170 |
Fibrogammin® 1250 |
- |
- |
- |
- |
051 1件: 51 💬 |
171 |
Fibrogammin®p, coagulation factor xiii concentrate (human) |
Factor XIII (human) |
- |
- |
- |
051 1件: 51 💬 |
172 |
Filgrastim |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 27件: 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
173 |
Fludarabine |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
174 |
Fludarabine phosphate |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
028 11件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
175 |
Fresolimumab |
Fresolimumab |
1件: D09620 D09620 💬 |
TGFB1 3件: TGFB1, TGFB2, TGFB3 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
051 3件: 51, 222, 274 💬 |
176 |
From august 2020 'no additional treatment' |
- |
- |
- |
- |
051 1件: 51 💬 |
177 |
Ft011 |
- |
- |
- |
- |
051 1件: 51 💬 |
178 |
G-csf |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 16件: 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
179 |
G451990 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
180 |
Genetic: fcx-013 |
- |
- |
- |
- |
051 1件: 51 💬 |
181 |
Glivec |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
182 |
Glivec 100 mg filmtabletten |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
183 |
Glpg1690 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
184 |
Glycyrrhizin |
Glycyrrhizic acid |
1件: D00157 D00157 💬 |
- |
- |
051 1件: 51 💬 |
185 |
Gm-csf |
- |
- |
- |
- |
051 3件: 51, 60, 229 💬 |
186 |
Gran |
- |
- |
- |
- |
051 1件: 51 💬 |
187 |
Gs-248 |
- |
- |
- |
- |
051 1件: 51 💬 |
188 |
Gsk2330811 |
- |
- |
- |
- |
051 2件: 51, 96 💬 |
189 |
Gsk2330811 solution for injection, 100mg/ml |
- |
- |
- |
- |
051 1件: 51 💬 |
190 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
191 |
Hidonac*ev 1fl 5g 25ml |
- |
- |
- |
- |
051 1件: 51 💬 |
192 |
High-dose intravenous immunoglobulin (venoglobulin-ih) |
- |
- |
- |
- |
051 1件: 51 💬 |
193 |
Hizentra |
- |
- |
- |
- |
014 4件: 14, 50, 51, 65 💬 |
194 |
Human anti-transforming growth factor beta-1 monoclonal antibody |
- |
- |
- |
- |
051 1件: 51 💬 |
195 |
Human normal immunoglobulin |
Human immunoglobulin G |
- |
- |
- |
011 9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
196 |
Human normal immunoglobulin for intravenous (iv) administration |
Human immunoglobulin G |
- |
- |
- |
051 1件: 51 💬 |
197 |
Human normal immunoglobulin for intravenous administration |
Human immunoglobulin G |
- |
- |
- |
014 3件: 14, 51, 65 💬 |
198 |
Human normal immunoglobulin for subcutaneous administration |
Human immunoglobulin G |
- |
- |
- |
051 2件: 51, 65 💬 |
199 |
Hyaluronidase |
Hyaluronidase |
3件: D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
028 4件: 28, 51, 65, 331 💬 |
200 |
Hyaluronidase injected intradermally |
Hyaluronidase |
3件: D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
051 1件: 51 💬 |
201 |
Hyperimmune caprine serum |
- |
- |
- |
- |
051 1件: 51 💬 |
202 |
Hyperoxia |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
203 |
Ifetroban |
Ifetroban |
1件: D04500 D04500 💬 |
TBXA2R 1件: TBXA2R 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
051 3件: 51, 86, 113 💬 |
204 |
Igpro10 |
- |
- |
- |
- |
014 3件: 14, 51, 65 💬 |
205 |
Igpro20 |
- |
- |
- |
- |
014 4件: 14, 50, 51, 65 💬 |
206 |
Iguratimod |
Iguratimod |
1件: D01146 D01146 💬 |
NFKB1 1件: NFKB1 💬 |
AGE-RAGE signaling pathway in diabetic complications 72件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway |
046 4件: 46, 51, 53, 271 💬 |
207 |
Ilomedin |
- |
- |
- |
- |
051 1件: 51 💬 |
208 |
Iloprost |
Iloprost |
1件: D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 4件: 51, 84, 85, 86 💬 |
209 |
Iloprost injection, for intravenous use |
Iloprost |
1件: D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 1件: 51 💬 |
210 |
Iloprost low dose |
Iloprost |
1件: D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 1件: 51 💬 |
211 |
Iloprost sale di trometamolo |
Iloprost |
1件: D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 1件: 51 💬 |
212 |
Iloprost therapy up to 2 ng/kg x min |
Iloprost |
1件: D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 1件: 51 💬 |
213 |
Iloprost trometamol |
Iloprost |
2件: D00396 D00396, D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 1件: 51 💬 |
214 |
Imatinib |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
215 |
Imatinib mesilato |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
051 1件: 51 💬 |
216 |
Imatinib mesylate |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 5件: 13, 28, 34, 51, 86 💬 |
217 |
Imiquimod |
Imiquimod |
1件: D02500 D02500 💬 |
TLR7 1件: TLR7 💬 |
Coronavirus disease - COVID-19 5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway |
034 2件: 34, 51 💬 |
218 |
Imiquimod 5% cream |
Imiquimod |
1件: D02500 D02500 💬 |
TLR7 1件: TLR7 💬 |
Coronavirus disease - COVID-19 5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway |
034 2件: 34, 51 💬 |
219 |
Imnovid |
- |
- |
- |
- |
051 1件: 51 💬 |
220 |
Imnovid 1 mg hard capsules |
- |
- |
- |
- |
051 1件: 51 💬 |
221 |
Incb039110 |
- |
- |
- |
- |
051 2件: 51, 97 💬 |
222 |
Indocyanine green |
Indocyanine green |
1件: D01342 D01342 💬 |
- |
- |
046 7件: 46, 51, 96, 235, 278, 291, 296 💬 |
223 |
Indole |
Indole |
- |
- |
- |
051 1件: 51 💬 |
224 |
Influenza vaccine |
- |
- |
- |
- |
011 5件: 11, 13, 46, 51, 84 💬 |
225 |
Injection of allogeneic mesenchymal stem cells |
- |
- |
- |
- |
051 1件: 51 💬 |
226 |
Injection of autologous stromal vascular fraction |
- |
- |
- |
- |
051 1件: 51 💬 |
227 |
Interleukin 2 |
- |
- |
- |
- |
046 9件: 46, 49, 51, 56, 63, 95, 96, 97, 271 💬 |
228 |
Intravenous immunoglobulin |
- |
- |
- |
- |
013 8件: 13, 14, 35, 38, 39, 49, 51, 309 💬 |
229 |
Iontophoresis of treprostinil |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 1件: 51 💬 |
230 |
Itacitinib |
Itacitinib |
1件: D10944 D10944 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 5件: 46, 51, 60, 97, 228 💬 |
231 |
Iv cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
051 1件: 51 💬 |
232 |
Iva337 |
- |
- |
- |
- |
051 1件: 51 💬 |
233 |
Ivig |
Human immunoglobulin G |
- |
- |
- |
011 8件: 11, 13, 14, 17, 35, 50, 51, 65 💬 |
234 |
Jbt-101 |
- |
- |
- |
- |
049 4件: 49, 50, 51, 299 💬 |
235 |
Khk4827 |
- |
- |
- |
- |
037 2件: 37, 51 💬 |
236 |
Lactobacillus |
- |
- |
- |
- |
051 1件: 51 💬 |
237 |
Lanifibranor |
Lanifibranor |
- |
- |
- |
051 1件: 51 💬 |
238 |
Lenabasum |
- |
- |
- |
- |
050 3件: 50, 51, 299 💬 |
239 |
Lenabasum 20 mg |
- |
- |
- |
- |
050 3件: 50, 51, 299 💬 |
240 |
Lenabasum 20 mg powder in capsule |
- |
- |
- |
- |
051 1件: 51 💬 |
241 |
Lenabasum 5 mg |
- |
- |
- |
- |
050 3件: 50, 51, 299 💬 |
242 |
Lenabasum 5 mg powder in capsule |
- |
- |
- |
- |
051 1件: 51 💬 |
243 |
Leuprolide |
Leuprolide |
2件: D00989 D00989, D08113 D08113 💬 |
GNRHR 1件: GNRHR 💬 |
GnRH signaling pathway 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction |
001 5件: 1 , 2 , 3 , 51, 76 💬 |
244 |
Lidocaine |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 10件: 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
245 |
Lidocaine 2% without vessel constrictor |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 1件: 51 💬 |
246 |
Lipitor |
- |
- |
- |
- |
051 3件: 51, 96, 299 💬 |
247 |
Liposomal bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 3件: 51, 70, 96 💬 |
248 |
Mabp1 (bermekimab) |
Bermekimab |
1件: D11253 D11253 💬 |
IL1A 1件: IL1A 💬 |
AGE-RAGE signaling pathway in diabetic complications 21件: AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus |
051 1件: 51 💬 |
249 |
Mabthera |
- |
- |
- |
- |
011 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
250 |
Macitentan |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 5件: 51, 85, 86, 88, 210 💬 |
251 |
Macitentan 10 mg |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 3件: 51, 86, 88 💬 |
252 |
Macitentan 10mg |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
253 |
Macitentan 3 mg |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
254 |
Macitentan 3mg |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
255 |
Medi-546 |
- |
- |
- |
- |
049 2件: 49, 51 💬 |
256 |
Medi-551 |
- |
- |
- |
- |
013 2件: 13, 51 💬 |
257 |
Medrone |
- |
- |
- |
- |
046 4件: 46, 51, 83, 162 💬 |
258 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 11件: 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
259 |
Mesenchymal stem cells from wharton ´s jellyintravenous infusion of mesenchymal stem cells from wharton ´s jelly |
- |
- |
- |
- |
051 1件: 51 💬 |
260 |
Mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 9件: 2 , 36, 49, 51, 60, 96, 97, 274, 284 💬 |
261 |
Mesna |
- |
- |
- |
- |
011 11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
262 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
263 |
Methylprednisolon |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 4件: 13, 14, 51, 66 💬 |
264 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
265 |
Methylprednisolone acetate |
Acetate |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
051 1件: 51 💬 |
266 |
Methylprednisolone sodium succinate |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 6件: 13, 46, 49, 50, 51, 211 💬 |
267 |
Metoclopramide |
Metoclopramide |
3件: D00726 D00726, D02213 D02213, D05008 D05008 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
051 1件: 51 💬 |
268 |
Metoclopramide accord - 10 mg compresse 28 compresse in blister pvc/pvdc/al |
Metoclopramide |
3件: D00726 D00726, D02213 D02213, D05008 D05008 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
051 1件: 51 💬 |
269 |
Metronidazole |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 8件: 46, 51, 63, 94, 95, 96, 97, 291 💬 |
270 |
Mg |
- |
- |
- |
- |
006 3件: 6 , 13, 51 💬 |
271 |
Mhsct |
- |
- |
- |
- |
051 1件: 51 💬 |
272 |
Microgynon |
- |
- |
- |
- |
013 2件: 13, 51 💬 |
273 |
Mizoribine |
Mizoribine |
1件: D01392 D01392 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
046 8件: 46, 49, 51, 53, 66, 94, 222, 224 💬 |
274 |
Mmf |
- |
- |
- |
- |
013 13件: 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬 |
275 |
Mpa |
- |
- |
- |
- |
049 3件: 49, 51, 60 💬 |
276 |
Mqx-503 |
- |
- |
- |
- |
051 1件: 51 💬 |
277 |
Msc |
- |
- |
- |
- |
006 6件: 6 , 51, 60, 96, 97, 271 💬 |
278 |
Mt-7117 |
- |
- |
- |
- |
051 2件: 51, 254 💬 |
279 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
280 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
281 |
Mycophenolate mofetil (mmf) |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
013 7件: 13, 49, 51, 60, 65, 66, 222 💬 |
282 |
Mycophenolic acid |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 8件: 11, 43, 49, 51, 60, 66, 96, 222 💬 |
283 |
N-acetylcysteine (nac) |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
034 3件: 34, 51, 299 💬 |
284 |
Nac |
- |
- |
- |
- |
034 5件: 34, 51, 85, 90, 299 💬 |
285 |
Nd |
- |
- |
- |
- |
013 4件: 13, 46, 51, 97 💬 |
286 |
Neovasculgen |
- |
- |
- |
- |
051 1件: 51 💬 |
287 |
Neupogen |
- |
- |
- |
- |
013 4件: 13, 28, 51, 285 💬 |
288 |
Nilotinib |
Nilotinib |
1件: D08953 D08953 💬 |
ABL1 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 5件: 6 , 8 , 34, 51, 86 💬 |
289 |
Nilotinib (tasigna) |
Nilotinib |
1件: D08953 D08953 💬 |
ABL1 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
051 1件: 51 💬 |
290 |
Nintedanib |
Nintedanib |
1件: D10481 D10481 💬 |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 |
Adherens junction 34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway |
051 5件: 51, 85, 89, 227, 228 💬 |
291 |
Nitroglycerin |
Nitroglycerin |
1件: D00515 D00515 💬 |
- |
- |
051 1件: 51 💬 |
292 |
Nitroglycerin ointment 2% |
Nitroglycerin |
1件: D00515 D00515 💬 |
- |
- |
051 1件: 51 💬 |
293 |
Nitroglycerine |
Nitroglycerin |
1件: D00515 D00515 💬 |
- |
- |
046 2件: 46, 51 💬 |
294 |
Nitroglycerine gel |
Nitroglycerin |
1件: D00515 D00515 💬 |
- |
- |
051 1件: 51 💬 |
295 |
Nitroprusside |
Nitroprusside |
1件: D00614 D00614 💬 |
- |
- |
051 1件: 51 💬 |
296 |
Nivolumab |
Nivolumab |
1件: D10316 D10316 💬 |
PDCD1 1件: PDCD1 💬 |
Cell adhesion molecules 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
297 |
Non applicabile |
- |
- |
- |
- |
051 1件: 51 💬 |
298 |
Non propietry, therefore n/a |
- |
- |
- |
- |
051 1件: 51 💬 |
299 |
Null |
- |
- |
- |
- |
006 16件: 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
300 |
Ofev |
- |
- |
- |
- |
051 5件: 51, 85, 89, 227, 228 💬 |
301 |
Omeprazole |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
302 |
Omeprazole 20mg |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
051 1件: 51 💬 |
303 |
Onabotulinumtoxin a |
- |
- |
- |
- |
051 2件: 51, 226 💬 |
304 |
Ophthalmic emulsion |
- |
- |
- |
- |
051 2件: 51, 53 💬 |
305 |
Opsumit 10 mg tablet |
- |
- |
- |
- |
051 1件: 51 💬 |
306 |
Oral bovine type i collagen |
Bovine type I collagen |
- |
- |
- |
051 1件: 51 💬 |
307 |
Oral ifetroban |
Ifetroban |
1件: D04500 D04500 💬 |
TBXA2R 1件: TBXA2R 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
051 2件: 51, 86 💬 |
308 |
Oral treprostinil |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 2件: 51, 86 💬 |
309 |
Orencia |
- |
- |
- |
- |
044 13件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
310 |
Orm-12471 |
- |
- |
- |
- |
051 1件: 51 💬 |
311 |
Orm-12471 30mg |
- |
- |
- |
- |
051 1件: 51 💬 |
312 |
Orm-12741 |
ORM-12741 |
- |
- |
- |
051 1件: 51 💬 |
313 |
Other vasodilator |
- |
- |
- |
- |
051 1件: 51 💬 |
314 |
Other: biopsy |
- |
- |
- |
- |
051 1件: 51 💬 |
315 |
Other: bronchoalveolar samples |
- |
- |
- |
- |
051 1件: 51 💬 |
316 |
Other: flow cytometry |
- |
- |
- |
- |
028 3件: 28, 51, 60 💬 |
317 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
318 |
Other: physalis angulata ethanol extract |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 1件: 51 💬 |
319 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 5件: 34, 36, 51, 96, 298 💬 |
320 |
Other: questionnaire administration |
- |
- |
- |
- |
016 4件: 16, 34, 51, 298 💬 |
321 |
Other: rosemary essential oil |
Rosemary |
- |
- |
- |
051 1件: 51 💬 |
322 |
Other: sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
051 1件: 51 💬 |
323 |
Other: vasculopathy assessment |
- |
- |
- |
- |
051 1件: 51 💬 |
324 |
Ozone |
Ozone |
- |
- |
- |
049 2件: 49, 51 💬 |
325 |
P144 |
- |
- |
- |
- |
051 1件: 51 💬 |
326 |
P144 cream |
- |
- |
- |
- |
051 1件: 51 💬 |
327 |
P144 cytokine inhibitor |
- |
- |
- |
- |
051 1件: 51 💬 |
328 |
P144 cytokines inhibitors |
- |
- |
- |
- |
051 1件: 51 💬 |
329 |
P144 digna cream |
- |
- |
- |
- |
051 1件: 51 💬 |
330 |
P144. cytokines inhibitors |
- |
- |
- |
- |
051 1件: 51 💬 |
331 |
Paquinimod |
Paquinimod |
- |
- |
- |
049 2件: 49, 51 💬 |
332 |
Part b open-label extension |
- |
- |
- |
- |
051 1件: 51 💬 |
333 |
Patients will be randomized to receive ehp-101 |
- |
- |
- |
- |
051 1件: 51 💬 |
334 |
Penicillamine |
Penicillamine |
1件: D00496 D00496 💬 |
- |
- |
051 2件: 51, 171 💬 |
335 |
Peripheral blood stem cells |
- |
- |
- |
- |
051 2件: 51, 65 💬 |
336 |
Pfd |
- |
- |
- |
- |
051 2件: 51, 298 💬 |
337 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
338 |
Phosphodiesterase inhibitors |
- |
- |
- |
- |
051 1件: 51 💬 |
339 |
Physiological saline |
- |
- |
- |
- |
051 1件: 51 💬 |
340 |
Pirfenidone |
Pirfenidone |
1件: D01583 D01583 💬 |
CCL2 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 82件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
034 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
341 |
Pirfenidone (pfd) |
Pirfenidone |
1件: D01583 D01583 💬 |
CCL2 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 82件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 1件: 51 💬 |
342 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
343 |
Platelet gel |
- |
- |
- |
- |
051 1件: 51 💬 |
344 |
Plerixafor |
Plerixafor |
1件: D08971 D08971 💬 |
CXCR4 1件: CXCR4 💬 |
Axon guidance 12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor |
020 5件: 20, 51, 65, 285, 299 💬 |
345 |
Pletal |
- |
- |
- |
- |
051 1件: 51 💬 |
346 |
Polydeoxyribonucleotides |
- |
- |
- |
- |
051 2件: 51, 70 💬 |
347 |
Pomalidomida |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 1件: 51 💬 |
348 |
Pomalidomide |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 6件: 28, 34, 51, 85, 227, 331 💬 |
349 |
Pomalidomide (cc-4047) |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 1件: 51 💬 |
350 |
Pr1 |
- |
- |
- |
- |
051 1件: 51 💬 |
351 |
Prednisolon |
- |
- |
- |
- |
046 6件: 46, 50, 51, 66, 96, 97 💬 |
352 |
Prednisolona |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
051 1件: 51 💬 |
353 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
354 |
Prednisolone 5 mg |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 2件: 46, 51 💬 |
355 |
Prednisolone 5mg gastro-resistant tablets |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
051 1件: 51 💬 |
356 |
Prednisolone and taper |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
051 1件: 51 💬 |
357 |
Prednisoloni |
- |
- |
- |
- |
051 1件: 51 💬 |
358 |
Prednisolonum |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
051 1件: 51 💬 |
359 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
360 |
Prednizolon |
- |
- |
- |
- |
051 1件: 51 💬 |
361 |
Prednizolonas |
- |
- |
- |
- |
051 1件: 51 💬 |
362 |
Privigen |
- |
- |
- |
- |
011 4件: 11, 14, 51, 65 💬 |
363 |
Procedure: 2 ml of whole blood sample will be collected on edta tube |
Edetic acid |
8件: D00052 D00052, D00571 D00571, D01802 D01802, D03943 D03943, D03944 D03944, D03945 D03945, D03946 D03946, D03947 D03947 💬 |
- |
- |
051 1件: 51 💬 |
364 |
Procedure: adipose tissue harvest |
- |
- |
- |
- |
051 1件: 51 💬 |
365 |
Procedure: allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 8件: 28, 51, 60, 62, 65, 164, 284, 285 💬 |
366 |
Procedure: autologous hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 6件: 11, 13, 14, 28, 49, 51 💬 |
367 |
Procedure: biopsy |
- |
- |
- |
- |
051 3件: 51, 78, 193 💬 |
368 |
Procedure: bone marrow transplantation |
- |
- |
- |
- |
051 4件: 51, 60, 284, 285 💬 |
369 |
Procedure: leukapheresis |
- |
- |
- |
- |
049 5件: 49, 51, 96, 284, 285 💬 |
370 |
Procedure: leukopheresis |
- |
- |
- |
- |
051 1件: 51 💬 |
371 |
Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 6件: 28, 51, 60, 62, 65, 285 💬 |
372 |
Procedure: order of two elements of surgical procedure |
- |
- |
- |
- |
051 1件: 51 💬 |
373 |
Procedure: peripheral blood stem cell transplantation |
- |
- |
- |
- |
011 11件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬 |
374 |
Procedure: quality-of-life assessment |
- |
- |
- |
- |
028 3件: 28, 34, 51 💬 |
375 |
Procedure: reduced intensity allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
051 1件: 51 💬 |
376 |
Procedure: reduced intensity allogeneic transplant |
- |
- |
- |
- |
049 2件: 49, 51 💬 |
377 |
Procedure: self bone marrow transplant |
- |
- |
- |
- |
051 1件: 51 💬 |
378 |
Procedure: stem cell transplantation |
- |
- |
- |
- |
019 6件: 19, 51, 60, 62, 65, 326 💬 |
379 |
Procedure: total body irradiation |
- |
- |
- |
- |
019 6件: 19, 20, 51, 60, 65, 285 💬 |
380 |
Procedure: total-body irradiation |
- |
- |
- |
- |
051 1件: 51 💬 |
381 |
Propylene glycol |
Propylene glycol |
1件: D00078 D00078 💬 |
- |
- |
028 2件: 28, 51 💬 |
382 |
Prostanoids |
- |
- |
- |
- |
051 1件: 51 💬 |
383 |
Prucalopride |
Prucalopride |
1件: D09205 D09205 💬 |
HTR4 1件: HTR4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
013 3件: 13, 51, 96 💬 |
384 |
Prucalopride succinate |
Prucalopride |
1件: D09205 D09205 💬 |
HTR4 1件: HTR4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
051 1件: 51 💬 |
385 |
Qax576 |
- |
- |
- |
- |
051 4件: 51, 85, 96, 98 💬 |
386 |
Rabbit |
Rabbit |
- |
- |
- |
011 8件: 11, 13, 49, 51, 60, 65, 96, 285 💬 |
387 |
Rabeprazole |
Rabeprazole |
2件: D00724 D00724, D08463 D08463 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
002 2件: 2 , 51 💬 |
388 |
Radiation: cone beam computed tomography (cbct) |
Tricyclazole |
- |
- |
- |
051 1件: 51 💬 |
389 |
Radiation: intensity-modulated radiation therapy |
- |
- |
- |
- |
051 1件: 51 💬 |
390 |
Radiation: total body irradiation |
- |
- |
- |
- |
036 7件: 36, 49, 51, 60, 65, 283, 284 💬 |
391 |
Radiation: total-body irradiation |
- |
- |
- |
- |
028 9件: 28, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
392 |
Rapamycin |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 18件: 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
393 |
Ratg |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 3件: 13, 51, 60 💬 |
394 |
Rbatg |
- |
- |
- |
- |
051 2件: 51, 96 💬 |
395 |
Recombinant humanized anti-human monoclonal antibody directed against the il-6r |
- |
- |
- |
- |
046 2件: 46, 51 💬 |
396 |
Relaxin |
- |
- |
- |
- |
051 1件: 51 💬 |
397 |
Resolor |
- |
- |
- |
- |
051 1件: 51 💬 |
398 |
Resolor*28cpr riv 2mg |
- |
- |
- |
- |
051 1件: 51 💬 |
399 |
Resunab, ajulemic acid, anabasum |
Ajulemic acid |
1件: D11312 D11312 💬 |
CNR2 1件: CNR2 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
050 3件: 50, 51, 299 💬 |
400 |
Rilonacept |
Rilonacept |
1件: D06635 D06635 💬 |
IL1A 2件: IL1A, IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
051 4件: 51, 106, 107, 266 💬 |
401 |
Ringer lactate |
- |
- |
- |
- |
051 1件: 51 💬 |
402 |
Riocigu |
- |
- |
- |
- |
051 1件: 51 💬 |
403 |
Riociguat |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 6件: 51, 84, 86, 88, 225, 299 💬 |
404 |
Riociguat (adempas, bay63-2521) |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 4件: 51, 86, 88, 299 💬 |
405 |
Riociguat coated tablet 0.5 mg |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
406 |
Riociguat coated tablet 1.0 mg |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
407 |
Riociguat coated tablet 1.5 mg |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
408 |
Riociguat coated tablet 2.0 mg |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
409 |
Riociguat coated tablet 2.5 m |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
410 |
Riociguat coated tablet 2.5 mg |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
411 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
412 |
Ro 47-0203 |
- |
- |
- |
- |
051 4件: 51, 85, 86, 88 💬 |
413 |
Ro 487-7533/f10-04 |
- |
- |
- |
- |
041 4件: 41, 46, 51, 107 💬 |
414 |
Ro47-0203 / act-050088 |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
415 |
Ro487-7533/f10-04 |
- |
- |
- |
- |
046 2件: 46, 51 💬 |
416 |
Roactemra |
- |
- |
- |
- |
040 9件: 40, 41, 46, 51, 86, 107, 266, 271, 331 💬 |
417 |
Roactemra 162 mg |
- |
- |
- |
- |
046 2件: 46, 51 💬 |
418 |
Rosemary |
Rosemary |
- |
- |
- |
051 1件: 51 💬 |
419 |
Rosuvastatin |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
420 |
Saccharomyces |
- |
- |
- |
- |
051 1件: 51 💬 |
421 |
Saccharomyces boulardii oral tablet |
- |
- |
- |
- |
051 1件: 51 💬 |
422 |
Sar100842 |
- |
- |
- |
- |
051 1件: 51 💬 |
423 |
Sar156597 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
424 |
Sar156597 (act14604) |
- |
- |
- |
- |
051 1件: 51 💬 |
425 |
Sar231893 |
- |
- |
- |
- |
051 2件: 51, 160 💬 |
426 |
Selexipag |
Selexipag |
1件: D09994 D09994 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 5件: 51, 70, 84, 86, 88 💬 |
427 |
Sildenafil |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
428 |
Sildenafil 20mg |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 2件: 51, 86 💬 |
429 |
Sildenafil 20mg and bosentan 62.5mg |
Bosentan |
4件: D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA 3件: EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 2件: 51, 86 💬 |
430 |
Sildenafil citrate |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 4件: 51, 85, 86, 225 💬 |
431 |
Sildenafil therapy |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
432 |
Simvastatin |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 21件: 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
433 |
Sinvacor |
- |
- |
- |
- |
051 1件: 51 💬 |
434 |
Sinvacor*28cpr riv 20mg |
- |
- |
- |
- |
051 1件: 51 💬 |
435 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
436 |
Sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
437 |
Sodium fluoride |
Sodium fluoride |
1件: D00943 D00943 💬 |
- |
- |
051 1件: 51 💬 |
438 |
Sodium fluoride 18f |
Sodium fluoride |
1件: D00943 D00943 💬 |
- |
- |
051 1件: 51 💬 |
439 |
Sodium nitroprusside |
Nitroprusside |
1件: D00614 D00614 💬 |
- |
- |
051 1件: 51 💬 |
440 |
Sodium thiosulfate |
- |
- |
- |
- |
050 2件: 50, 51 💬 |
441 |
Sodium thiosulfate 10% |
- |
- |
- |
- |
050 2件: 50, 51 💬 |
442 |
Sodium thiosulfate pentahydrate |
- |
- |
- |
- |
050 2件: 50, 51 💬 |
443 |
Solu-medrol |
- |
- |
- |
- |
013 7件: 13, 49, 50, 51, 53, 97, 211 💬 |
444 |
Solu-medrone |
- |
- |
- |
- |
051 3件: 51, 83, 162 💬 |
445 |
Soluble ve cadherin |
- |
- |
- |
- |
051 1件: 51 💬 |
446 |
Standard of care |
- |
- |
- |
- |
006 12件: 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
447 |
Sterile saline solution |
- |
- |
- |
- |
051 1件: 51 💬 |
448 |
Steroids |
- |
- |
- |
- |
046 7件: 46, 50, 51, 63, 66, 96, 97 💬 |
449 |
Sti571 |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
450 |
Stromal vascular fraction |
- |
- |
- |
- |
051 1件: 51 💬 |
451 |
Sts |
- |
- |
- |
- |
050 2件: 50, 51 💬 |
452 |
Study of the gene expression profile |
- |
- |
- |
- |
051 1件: 51 💬 |
453 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
454 |
Tadalafil |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 7件: 6 , 51, 75, 84, 86, 113, 210 💬 |
455 |
Tadalafil and ambrisentan upfront combination therapy |
Ambrisentan |
2件: D02008 D02008, D07077 D07077 💬 |
EDNRA 2件: EDNRA, PDE5A 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 2件: 51, 86 💬 |
456 |
Tepezza |
- |
- |
- |
- |
051 1件: 51 💬 |
457 |
Terguride |
Terguride |
1件: D01348 D01348 💬 |
DRD2 2件: DRD2, PRL 💬 |
Alcoholism 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
051 2件: 51, 86 💬 |
458 |
Terguride hydrogenmaleate |
Terguride |
1件: D01348 D01348 💬 |
DRD2 2件: DRD2, PRL 💬 |
Alcoholism 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
051 1件: 51 💬 |
459 |
Thalidomide |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 20件: 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
460 |
Thiotepa |
Thiotepa |
1件: D00583 D00583 💬 |
- |
- |
013 11件: 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬 |
461 |
Thymoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
036 6件: 36, 51, 60, 65, 96, 326 💬 |
462 |
Thymoglobuline |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 5件: 13, 36, 51, 60, 96 💬 |
463 |
Tocilizumab |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
464 |
Tocilizumab [roactemra/actemra] |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 4件: 46, 51, 107, 331 💬 |
465 |
Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs) |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
051 1件: 51 💬 |
466 |
Tofacitinib |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
467 |
Topical amphimatrix |
- |
- |
- |
- |
051 1件: 51 💬 |
468 |
Topical amphimatrix with nitroglycerin (mqx-503) |
Nitroglycerin |
1件: D00515 D00515 💬 |
- |
- |
051 1件: 51 💬 |
469 |
Topical calcipotriene 0.005% ointment |
Calcipotriol |
1件: D01125 D01125 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
051 1件: 51 💬 |
470 |
Topical organogel with nitroglycerin |
Nitroglycerin |
1件: D00515 D00515 💬 |
- |
- |
051 1件: 51 💬 |
471 |
Tracleer |
- |
- |
- |
- |
013 8件: 13, 51, 84, 85, 86, 88, 210, 211 💬 |
472 |
Tracleer*125mg 56cpr riv. |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
473 |
Tracleer*56cpr riv 125mg |
- |
- |
- |
- |
051 3件: 51, 86, 88 💬 |
474 |
Transdihydrolisuride |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
475 |
Treprostinil |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 6件: 51, 84, 85, 86, 88, 210 💬 |
476 |
Treprostinil diethanolamine |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 2件: 51, 86 💬 |
477 |
Treprostinil sodium |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 3件: 51, 86, 88 💬 |
478 |
Trimebutine |
Trimebutine |
1件: D08639 D08639 💬 |
OPRK1 2件: OPRK1, OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
051 1件: 51 💬 |
479 |
Trometamol |
Tromethamine |
1件: D00396 D00396 💬 |
- |
- |
051 1件: 51 💬 |
480 |
Ucmsc |
- |
- |
- |
- |
051 2件: 51, 94 💬 |
481 |
Urine sample |
- |
- |
- |
- |
049 3件: 49, 51, 61 💬 |
482 |
Ut-15 sr |
- |
- |
- |
- |
051 1件: 51 💬 |
483 |
Ut-15c sr |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
484 |
Ut-15c-sr |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
485 |
Vaseline |
- |
- |
- |
- |
051 1件: 51 💬 |
486 |
Veledimex |
Veledimex |
1件: D10678 D10678 💬 |
- |
- |
051 1件: 51 💬 |
487 |
Vessel |
- |
- |
- |
- |
013 4件: 13, 51, 271, 288 💬 |
488 |
Vib7734 |
- |
- |
- |
- |
049 4件: 49, 50, 51, 53 💬 |
489 |
Vip |
- |
- |
- |
- |
049 3件: 49, 51, 86 💬 |
490 |
Vivomixx probiotics |
- |
- |
- |
- |
051 1件: 51 💬 |
491 |
Volibris |
- |
- |
- |
- |
051 4件: 51, 85, 86, 88 💬 |
492 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
493 |
Yellow fever vaccine |
Yellow Fever Vaccine |
1件: D06347 D06347 💬 |
- |
- |
040 7件: 40, 44, 46, 50, 51, 52, 53 💬 |
494 |
Yellow fever vaccine (17d) |
Yellow Fever Vaccine |
1件: D06347 D06347 💬 |
- |
- |
040 7件: 40, 44, 46, 50, 51, 52, 53 💬 |
495 |
Zd4054 |
- |
- |
- |
- |
051 1件: 51 💬 |
496 |
Zibotentan |
Zibotentan |
1件: D07741 D07741 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
497 |
Ziritaxestat |
Ziritaxestat |
1件: D11844 D11844 💬 |
ENPP2 1件: ENPP2 💬 |
Ether lipid metabolism 1件: Ether lipid metabolism |
051 2件: 51, 85 💬 |